BlackRock’s Edwards Lifesciences EW Stock Holding History

BlackRock’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.1M	Buy	+138,000	New	+$11.4M	﹤0.01%	3431
2024 Q4	–	Sell	-644,500	Closed	-$42.5M	–	5410
2024 Q3	$42.5M	Buy	+644,500	New	+$46.8M	﹤0.01%	2569
2024 Q2	–	Sell	-813,000	Closed	-$77.7M	–	5305
2024 Q1	$77.7M	Buy	+813,000	New	+$68.3M	﹤0.01%	2203
2021 Q2	–	Sell	-312,200	Closed	-$26.1M	–	5503
2021 Q1	$26.1M	Buy	+312,200	New	+$26.4M	﹤0.01%	3038
2014 Q1	–	Sell	-60,000	Closed	-$658K	–	3135
2013 Q4	$658K	Buy	+60,000	New	+$676K	﹤0.01%	1285

Other funds holding EW

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

BlackRock's EW Position: Q1 2026 in Review

BlackRock increased its Edwards Lifesciences (EW) stake by 0.25% in Q1 2026, buying an estimated $10.6M and bringing the position to 52,590,933 shares worth $4.21B. The position accounts for 0.07% of the portfolio, ranked #230.

BlackRock first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.39B in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

BlackRock held 52,590,933 shares of Edwards Lifesciences worth $4.21B as of Q1 2026.
BlackRock bought 129,018 Edwards Lifesciences shares in Q1 2026, an estimated $10.6M.
Edwards Lifesciences made up 0.07% of BlackRock's portfolio in Q1 2026, its #230 holding.
BlackRock first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
BlackRock's Edwards Lifesciences position peaked at $7.39B in Q4 2021.
1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.